Interested in a researcher position? Apply now to the Hernandez lab! We’re looking for people at all levels! Reach out here or at [email protected] uab.taleo.net/careersection/…

Wonderful group photo from the ALS and Related Motor Neuron Diseases Gordon Research Conference (also featuring the famous GRC 🐄)! Gordon Research Conferences #ALS #MND #GRC 🧠🧪⚕️🏔️🌞🌺🇨🇭

Rescue of FTLD-associated TDP-43 pathology and neurodegeneration by peripheral AAV-mediated expression of brain-penetrant progranulin biorxiv.org/content/10.110…

Multivalent GU-rich oligonucleotides sequester TDP-43 in the nucleus by inducing high molecular weight RNP complexes -- very exciting results from our colleagues in the lab of Dr. Lindsey Hayes! biorxiv.org/content/10.110…

Just hours before the start of the 1st Conference on “TDP-43 function and dysfunction in disease” in beautiful Trieste, Italy. ⁦ICGEB Official⁩. Can’t wait to see everyone!

So grateful to have been given the opportunity to present my research at the 1st Biennial Conference on TDP-43 Function and Dysfunction in Disease in the beautiful Trieste, Italy! Thank you so much Live Like Lou for sponsoring my trip to this insightful and productive conference!

Many of our Live Like Lou emerging ALS investigators attended an ALS research conference in Italy last week. We were proud to sponsor this conference which focused on TDP-43 function and dysfunction in disease.

🔬Andrew Arrant, Ph.D., and Briana De Miranda, Ph.D. have been selected as recipients of The American Parkinson Disease Association!🧠 APDA allocates $1.975 million for groundbreaking PD research in 2023-2024! 🧪 Read more: go.uab.edu/46sRkrr

I loved being able to attend the BrightFocus Foundation Alzheimer’s FastTrack! The talks were fantastic and I was thrilled to be able to connect with so many peers and mentors. Now on to SfN! 🧠

If anyone is up early at SfN tomorrow, come check out my talk at 8:30! I’ll be talking about my mouse model to study how progranulin insufficiency is related to TDP-43 pathology!

Want to deliver gene therapies broadly, but activate them only in diseased neurons? TDP-REG "hacks" TDP cryptic mis-splicing to drive expression only WHEN and WHERE needed! Less toxicity, wider therapeutic window, new options for sporadic ALS therapies. biorxiv.org/content/10.110…

My favorite Society for Neuroscience (SfN) so far! I saw so much amazing science, gave my first nanosymposium talk, and spent time with so many new and old friends.

Me and the girlies after finishing MD-PhD/residency/fellowship/postdoc

🏆 South Carolina Women's Basketball ARE YOUR 2024  NATIONAL CHAMPIONS 🏆 #NationalChampionship

And we’re off! Don’t forget to tag us in your amazing work during the conference #isftd2024

I had such a great time at the International Society for Frontotemporal Dementias conference! It was wonderful learning about clinical and basic research, and everything in between. I’m so thankful for the opportunity to present my research and connect with new and old friends! #isftd2024

Our paper on cryptic splicing-controlled protein expression, which we hope will inspire safer and more adventurous gene therapy approaches for ALS and FTD, has been published in Science Magazine science.org/doi/10.1126/sc…

Stop by my poster tomorrow to hear about how progranulin insufficiency influences inflammation in response to TDP-opathy! October 6th from 8-12, poster C13! #sfn2024

At SfN? Stop by posters 119 and 120 this afternoon to hear about how Carboxy-terminal modifications on progranulin can improve AAV-progranulin gene therapy!

Had a great time at my last SfN of my PhD! I really appreciated all the insightful discussions at my poster and learned so much at all the talks! Society for Neuroscience (SfN) #SfN24